Ranq Pharmaceuticals And Excipients Private Limited, a active private limited company, was established on 02 August 1991 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1991PTC062793. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.33 M.
It upholds a compliant status. Its leadership includes Sameer Gajanan Ranadive (Director), Janhavi Bhargav Jangle (Director). Past directors included Hemant Naiknavare Dattaji, Gauri Hemant Naiknavare, Sudha Gajanan Ranadive. It holds ₹8.13 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No.112, 1St Floor, Ganatra Industrial Estate Next To Punjani Estate,Pokharan Road No., 1 Khopat ,, Thane, Maharashtra, 400601.
U24230MH1991PTC062793
062793
02 August 1991
₹2.00 M
₹1.33 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ranq Pharmaceuticals And Excipients Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sameer Gajanan Ranadive | Director | 02 Aug 1991 | Current |
| Janhavi Bhargav Jangle | Director | 18 Jul 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2013 | Past |
| Pramod Abcsdd | Director | 01 Jul 2014 | Past |
| Pramod Abcsdd | Director | 31 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ranq Pharmaceuticals And Excipients Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.55% decrease. The company also saw a substantial fall in profitability, with a 79.02% decrease in profit. The company's net worth moved up by a moderate rise of 0.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ranq Pharmaceuticals And Excipients had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,125,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 1995 | Bank Of Baroda | ₹1.60 M | Open |
| 02 Jun 1995 | Bank Of Baroda | ₹0.73 M | Open |
| 02 Jan 1992 | The Maharashtra State Financial Corpn. | ₹5.80 M | Open |
Explore comprehensive loan charge details -
Ranq Pharmaceuticals And Excipients has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ranq Pharmaceuticals And Excipients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranq Pharmaceuticals And Excipients's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ranq Pharmaceuticals And Excipients Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ranq Pharmaceuticals And Excipients Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Janhavi Bhargav Jangle was appointed as a Director was appointed as a Director on 18 Jul 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.
A charge with Bank Of Baroda amounted to Rs. 1.60 M with Charge ID 90153178 was registered on 16 Aug 1995. was recorded as a recent event.
Progress on A charge with Bank Of Baroda amounted to Rs. 0.73 M with Charge ID 90153144 was registered on 02 Jun 1995. was documented.
A charge with Bank Of Baroda of Rs. 0.73 M registered on 02 Jun 1995 with Charge ID 90153144 was modified on 02 Jun 1995. was recorded as a recent event.
The CIN of Ranq Pharmaceuticals And Excipients Private Limited is U24230MH1991PTC062793.
Ranq Pharmaceuticals And Excipients Private Limited is headquartered at Gala No.112, 1St Floor, Ganatra Industrial Estate Next To Punjani Estate,Pokharan Road No., 1 Khopat ,, Thane, Maharashtra, 400601.
Ranq Pharmaceuticals And Excipients Private Limited was incorporated on 02 August 1991.
The current directors of Ranq Pharmaceuticals And Excipients Private Limited are
The primary industry of Ranq Pharmaceuticals And Excipients Private Limited is Manufacturing.
Ranq Pharmaceuticals And Excipients Private Limited is unlisted.
The authorized capital of Ranq Pharmaceuticals And Excipients Private Limited is ₹2.00 M, and the paid-up capital is ₹1.33 M.
The compliance status of Ranq Pharmaceuticals And Excipients Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX